• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主和病原体遗传变异问题:开发普遍有效的结核病疫苗接种和个体化免疫治疗策略:潜在解决方案?

The Problem of Host and Pathogen Genetic Variability for Developing Strategies of Universally Efficacious Vaccination against and Personalised Immunotherapy of Tuberculosis: Potential Solutions?

机构信息

Department of Biochemistry, Microbiology and Immunology, Health Sciences Building, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada.

出版信息

Int J Mol Sci. 2023 Jan 18;24(3):1887. doi: 10.3390/ijms24031887.

DOI:10.3390/ijms24031887
PMID:36768222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9916249/
Abstract

Rational vaccination against and immunotherapy of any infectious disease requires knowledge of how protective and non-protective immune responses differ, and how immune responses are regulated, so their nature can be controlled. Strong Th1 responses are likely protective against Understanding how immune class regulation is achieved is pertinent to both vaccination and treatment. I argue that variables of infection, other than PAMPs, primarily determine the class of immunity generated. The alternative, non-PAMP framework I favour, allows me to propose strategies to achieve efficacious vaccination, transcending host and pathogen genetic variability, to prevent tuberculosis, and personalised protocols to treat disease.

摘要

理性的疫苗接种和任何传染病的免疫治疗都需要了解保护性和非保护性免疫反应的区别,以及免疫反应是如何调节的,从而控制其性质。强烈的 Th1 反应可能对理解免疫类别的调节是如何实现的与疫苗接种和治疗都有关。我认为,除了 PAMPs 之外,感染的变量主要决定了产生的免疫类型。我赞成的非 PAMP 框架使我能够提出策略来实现有效的疫苗接种,克服宿主和病原体遗传变异性,以预防结核病,并制定个性化的治疗方案。

相似文献

1
The Problem of Host and Pathogen Genetic Variability for Developing Strategies of Universally Efficacious Vaccination against and Personalised Immunotherapy of Tuberculosis: Potential Solutions?宿主和病原体遗传变异问题:开发普遍有效的结核病疫苗接种和个体化免疫治疗策略:潜在解决方案?
Int J Mol Sci. 2023 Jan 18;24(3):1887. doi: 10.3390/ijms24031887.
2
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
3
Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.卡介苗接种后对结核分枝杆菌DosR调控子蛋白缺乏免疫反应。
Infect Immun. 2007 Jul;75(7):3523-30. doi: 10.1128/IAI.01999-06. Epub 2007 May 14.
4
Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.用表达抗原Ag85B和Rv3425的慢病毒载体疫苗和DNA疫苗进行初免-加强卡介苗接种可提高小鼠对结核分枝杆菌的保护效力。
Immunology. 2014 Oct;143(2):277-86. doi: 10.1111/imm.12308.
5
The impact of transcriptomics on the fight against tuberculosis: focus on biomarkers, BCG vaccination, and immunotherapy.转录组学在抗击结核病中的作用:聚焦生物标志物、卡介苗接种及免疫疗法。
Clin Dev Immunol. 2011;2011:192630. doi: 10.1155/2011/192630. Epub 2010 Dec 20.
6
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
7
The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.候选结核病疫苗MVA85A可诱导高度持久的Th1反应。
PLoS One. 2014 Feb 3;9(2):e87340. doi: 10.1371/journal.pone.0087340. eCollection 2014.
8
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.针对结核分枝杆菌肉芽肿的宿主导向治疗:综述
Semin Immunopathol. 2016 Mar;38(2):167-83. doi: 10.1007/s00281-015-0537-x. Epub 2015 Oct 28.
9
Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis.宿主对结核分枝杆菌保护性免疫反应中的宿主反应及抗原。
Scand J Immunol. 1997 Feb;45(2):115-31. doi: 10.1046/j.1365-3083.1997.d01-380.x.
10
Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection.勿惊醒沉睡的巨人:宿主-病原体相互作用的新见解为潜伏性结核分枝杆菌感染的疫苗接种确定了新靶点。
Biol Chem. 2008 May;389(5):497-511. doi: 10.1515/bc.2008.057.

引用本文的文献

1
Measures to accelerate recovery from stage III tuberculous empyema: tuberculous empyema surgical and recovery methods.加速Ⅲ期结核性脓胸康复的措施:结核性脓胸的外科治疗及康复方法。
Perioper Med (Lond). 2025 Apr 17;14(1):43. doi: 10.1186/s13741-025-00530-y.
2
What Determines the Class of Immunity an Antigen Induces? A Foundational Question Whose Rational Consideration Has Been Undermined by the Information Overload.是什么决定了抗原诱导的免疫类别?一个基本问题,其合理思考已因信息过载而受到影响。
Biology (Basel). 2023 Sep 19;12(9):1253. doi: 10.3390/biology12091253.

本文引用的文献

1
Analyzing some concepts of immune regulation of the last three decades: Fostering greater research resilience despite the information overload. A personal view.分析过去三十年中免疫调节的一些概念:在信息过载的情况下培养更强的研究适应能力。个人观点。
Front Immunol. 2022 Nov 2;13:960742. doi: 10.3389/fimmu.2022.960742. eCollection 2022.
2
Facing the Increased Prevalence of Antibiotic-Resistant : Exploring the Feasibility of Realising Koch's Aspiration of Immunotherapy of Tuberculosis.面对抗生素耐药性的日益普遍:探索实现科赫结核病免疫治疗愿望的可行性。
Antibiotics (Basel). 2022 Mar 10;11(3):371. doi: 10.3390/antibiotics11030371.
3
Can interruption/withdrawl of anti-retroviral therapy provide personalized immunotherapy against HIV-1?
抗逆转录病毒疗法的中断/撤退能否提供针对 HIV-1 的个体化免疫疗法?
Scand J Immunol. 2020 Dec;92(6):e12934. doi: 10.1111/sji.12934. Epub 2020 Jul 30.
4
Miliary tuberculosis: A new look at an old foe.粟粒性肺结核:对老对手的新审视。
J Clin Tuberc Other Mycobact Dis. 2016 Mar 18;3:13-27. doi: 10.1016/j.jctube.2016.03.003. eCollection 2016 May.
5
On Analyzing How the Th1/Th2 Phenotype of an Immune Response Is Determined: Classical Observations Must Not Be Ignored.关于分析免疫应答的 Th1/Th2 表型如何确定:经典观察不能被忽视。
Front Immunol. 2019 Jun 5;10:1234. doi: 10.3389/fimmu.2019.01234. eCollection 2019.
6
Does T Cell Activation Require a Quorum of Lymphocytes?T 细胞激活是否需要淋巴细胞的群体感应?
J Immunol. 2018 Nov 15;201(10):2855-2861. doi: 10.4049/jimmunol.1800805.
7
A hypothesis for the existence of two types of tuberculosis, reflecting two distinct types of immune failure to control the pathogen, based upon prevalence of mycobacterium-specific IgG subclasses.基于分枝杆菌特异性 IgG 亚类的流行情况,提出存在两种类型结核的假说,反映了机体对病原体控制的两种不同类型的免疫失败。
Scand J Immunol. 2018 Jun;87(6):e12665. doi: 10.1111/sji.12665. Epub 2018 May 2.
8
Control of adaptive immunity by the innate immune system.固有免疫系统对适应性免疫的调控。
Nat Immunol. 2015 Apr;16(4):343-53. doi: 10.1038/ni.3123.
9
The number of responding CD4 T cells and the dose of antigen conjointly determine the TH1/TH2 phenotype by modulating B7/CD28 interactions.应答 CD4 T 细胞的数量和抗原的剂量通过调节 B7/CD28 相互作用共同决定了 TH1/TH2 表型。
J Immunol. 2014 Jun 1;192(11):5140-50. doi: 10.4049/jimmunol.1301691. Epub 2014 Apr 21.
10
On the mechanism determining the TH1/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases.在确定免疫应答的 TH1/TH2 表型的机制及其与某些传染病的预防和治疗策略的相关性方面。
Scand J Immunol. 2014 Jun;79(6):361-76. doi: 10.1111/sji.12175.